Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Midazolam
Epistatus
Routinely available
SMC (1279/17)
09/11/2023
Indication
Treatment of prolonged, acute, convulsive seizures in children and adolescents aged 10 to less than 18 years.
Therapeutic Area
Central nervous system
Status Description
Routinely available in line with national guidance
Formulation
10mg/1mL oromucosal solution prefilled syringe
Comments
-
Link to Advice
Advice Published
13/11/2017
SMC Submission Type
Abbreviated
SMC Status
Accepted